Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Intel Strategy for Achieving Wealth and Off Topic -- Ignore unavailable to you. Want to Upgrade?

To: Sonki who wrote (12802)	11/4/1997 8:31:00 PM
From: Mitchel S. Untracht	Respond to of 27012

i have mentioned in previous posts green tree and conseco. excellent selections. love travelers but missed boat on re-entry at 65. as far as drugs and medical cos. - i am a doctor and do not own any drug or medical equiptment cos. at this time. companies like medtronic are fantastic, but if i had real courage i would short it, since there is no way you can justify it's lofty valuation. i agree that there is a growing population that will be dependent on drugs. however, issues re: patent expiration that exist with merck are real. pfizer and warner-lambert great companies, terrible valuations. presently, i play the following game - when a great company, that often is given a high multiple, sells off for reasons such as currency issues, issues not related to the fundamentals of the company i like to get in cheap. one example where this has worked well this year is boston scientfic. i have a drip with jnj as they are a hybrid multinational with a strong presence in the medical field. there products are used everyday in many ways in all hospitals, outpatient areas and offices. they produce drugs, and all types of medical equiptment. they to have a lofty valuation and as a result am not interested in timing a big purchase, hence the drip. with all the issues in asia and europe, and the lack of reasonable valuations in the pharmaceuticals, i have recently been looking at drug stores. although great competition exists, companies like walgreens seem allow one to benefit from the increase use in prescriptions drugs as well as enter the retail sector in one stock selection IMO

To: Sonki who wrote (12802)	11/4/1997 8:31:00 PM
From: Mitchel S. Untracht	Respond to of 27012

i have mentioned in previous posts green tree and conseco. excellent selections. love travelers but missed boat on re-entry at 65. as far as drugs and medical cos. - i am a doctor and do not own any drug or medical equiptment cos. at this time. companies like medtronic are fantastic, but if i had real courage i would short it, since there is no way you can justify it's lofty valuation. i agree that there is a growing population that will be dependent on drugs. however, issues re: patent expiration that exist with merck are real. pfizer and warner-lambert great companies, terrible valuations. presently, i play the following game - when a great company, that often is given a high multiple, sells off for reasons such as currency issues, issues not related to the fundamentals of the company i like to get in cheap. one example where this has worked well this year is boston scientfic. i have a drip with jnj as they are a hybrid multinational with a strong presence in the medical field. there products are used everyday in many ways in all hospitals, outpatient areas and offices. they produce drugs, and all types of medical equiptment. they to have a lofty valuation and as a result am not interested in timing a big purchase, hence the drip. with all the issues in asia and europe, and the lack of reasonable valuations in the pharmaceuticals, i have recently been looking at drug stores. although great competition exists, companies like walgreens seem allow one to benefit from the increase use in prescriptions drugs as well as enter the retail sector in one stock selection IMO

To: Sonki who wrote (12802)	11/4/1997 8:39:00 PM
From: Mitchel S. Untracht	Respond to of 27012

hate to say it. but if you want a safe, minimum 15% going forward, would take a long hard look at Phillip Morris. i know all the negatives. so does the street and it is reflected in it's price. with 4% dividend looks better play next 6-12 months than any drug or large cap tech that i can think of at this time